FDA Staff Flags Lack Of Data On Abuse Potential For Opioid
The U.S. Food and Drug Administration on Monday said that Canadian drugmaker Intellipharmaceutics International Inc. didn't include data on the likelihood that its long-acting opioid painkiller could be abused in its...To view the full article, register now.
Already a subscriber? Click here to view full article